These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27595917)

  • 41. Building a flexible, voluntary donation panel: an exploration of donor willingness.
    Bagot KL; Masser BM; Starfelt LC; White KM
    Transfusion; 2016 Jan; 56(1):186-94. PubMed ID: 26408074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attitudes towards blood donation in Trinidad and Tobago.
    Sampath S; Ramsaran V; Parasram S; Mohammed S; Latchman S; Khunja R; Budhoo D; Poon King C; Charles KS
    Transfus Med; 2007 Apr; 17(2):83-7. PubMed ID: 17430463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New donors, loyal donors, and regular donors: Which motivations sustain blood donation?
    Guiddi P; Alfieri S; Marta E; Saturni V
    Transfus Apher Sci; 2015 Jun; 52(3):339-44. PubMed ID: 25797792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute hepatitis B virus window-period blood donations detected by individual-donation nucleic acid testing: a report on the first two cases found and interdicted in Spain.
    González R; Echevarria JM; Avellón A; Barea L; Castro E
    Transfusion; 2006 Jul; 46(7):1138-42. PubMed ID: 16836560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trend of blood donors entering the coronavirus pandemic era and challenges: Age-period-cohort analysis using 75.5 million all blood donations data during 2006-2020 in Japan.
    Imada H; Akita T; Sugiyama A; Tanaka J
    Transfusion; 2023 Jun; 63(6):1184-1194. PubMed ID: 37158239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood safety and availability: continuing challenges in China's blood banking system.
    Shi L; Wang JX; Stevens L; Ness P; Shan H
    Transfusion; 2014 Feb; 54(2):471-82. PubMed ID: 23710600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management.
    Kiely P; Thomas B; Kebede M
    Transfusion; 2008 Sep; 48(9):1833-41. PubMed ID: 18503614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individual and contextual determinants of blood donation frequency with a focus on clinic accessibility: a case study of Toronto, Canada.
    Cimaroli K; Páez A; Newbold KB; Heddle NM
    Health Place; 2012 Mar; 18(2):424-33. PubMed ID: 22226381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting first lifetime plasma donation among whole blood donors.
    Godin G; Germain M
    Transfusion; 2013 Dec; 53 Suppl 5():157S-61S. PubMed ID: 24341428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Donation frequency, iron loss, and risk of cancer among blood donors.
    Edgren G; Reilly M; Hjalgrim H; Tran TN; Rostgaard K; Adami J; Titlestad K; Shanwell A; Melbye M; Nyrén O
    J Natl Cancer Inst; 2008 Apr; 100(8):572-9. PubMed ID: 18398098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. role of altruistic behavior, empathetic concern, and social responsibility motivation in blood donation behavior.
    Steele WR; Schreiber GB; Guiltinan A; Nass C; Glynn SA; Wright DJ; Kessler D; Schlumpf KS; Tu Y; Smith JW; Garratty G;
    Transfusion; 2008 Jan; 48(1):43-54. PubMed ID: 17894795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
    Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
    JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; de Wit GA; Bonsel GJ; van Hout BA
    Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV, UK: 2002-2006.
    Davison KL; Dow B; Barbara JA; Hewitt PE; Eglin R
    Transfus Med; 2009 Feb; 19(1):24-34. PubMed ID: 19302452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seasonal blood shortages can be eliminated.
    Gilcher RO; McCombs S
    Curr Opin Hematol; 2005 Nov; 12(6):503-8. PubMed ID: 16217170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of hemoglobin in blood donors using a latent class mixed-effects transition model.
    Nasserinejad K; van Rosmalen J; de Kort W; Rizopoulos D; Lesaffre E
    Stat Med; 2016 Feb; 35(4):581-94. PubMed ID: 26467774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of the prevalence of iron deficiency and its related factors in blood donors of Yazd, Iran, 2003.
    Javadzadeh Shahshahani H; Attar M; Taher Yavari M
    Transfus Med; 2005 Aug; 15(4):287-93. PubMed ID: 16101806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [2-year anti-HIV donor screening in the Central Laboratory of the Swiss Red Cross Blood Transfusion Service].
    Lang O; Bachmann P; Baumgartner C; Bütler R
    Schweiz Med Wochenschr; 1988 Apr; 118(15):547-53. PubMed ID: 3375791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting future blood donor returns: past behavior, intentions, and observer effects.
    Ferguson E; Bibby PA
    Health Psychol; 2002 Sep; 21(5):513-8. PubMed ID: 12211519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of blood donor motivations.
    Paulson N; Travers H
    S D Med; 2015 Apr; 68(4):149-55. PubMed ID: 25946893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.